Live Programs

Advances in the Treatment of Diffuse Large B Cell Lymphoma: ADCs, Bispecific Antibodies, CAR T Therapies and Combinations
Live Virtual Webinar
Saturday, August 24, 2024: 10:00 AM Eastern Time, 9:00 AM Central Time, 8:00 AM Mountain Time, and 7:00 AM Pacific Time
https://www.mycme.com/courses/advances-in-the-treatment-of-diffuse-large-b-cell-lymphoma-9475

Myelofibrosis: Symptom Burden, Risk Stratification and Novel Treatments
Live Virtual Webinar
Saturday, August 10, 2024: 10:00 AM Eastern Time, 9:00 AM Central Time, 8:00 AM Mountain Time, and 7:00 AM Pacific Time
https://www.mycme.com/courses/myelofibrosis-symptom-burden-risk-stratification-and-novel-treatments-9511

Advances in Blood-based Biomarkers and Disease Modifying Anti-Amyloid Antibody Therapies for Early-Stage Alzheimer’s Disease
Live Virtual Webinar
Saturday, August 3, 2024: 10:00 AM Eastern Time, 9:00 AM Central Time, 8:00 AM Mountain Time, and 7:00 AM Pacific Time
https://www.mycme.com/courses/advances-in-blood-based-biomarkers-and-disease-modifying-anti-amyloid-antibody-therapies-for-early-stage-alzheimers-disease-9380

Ovarian Cancer: Optimizingthe Management Based on Mutations and Biomarkers to Direct Treatment with PARP Inhibitors and Immunotherapy
Live Virtual Webinar
Saturday, June 29, 2024: 10:00 AM Eastern Time, 9:00 AM Central Time, 8:00 AM Mountain Time, and 7:00 AM Pacific Time
https://www.mycme.com/courses/optimizing-the-management-of-ovarian-cancer-to-direct-treatment-with-parp-inhibitors-and-immunotherapy-9384

Glaucoma Management: Understanding Risk Factors, Screening and Treatment Options
Live Virtual Webinar
Saturday, April 27, 2024: 10:00 AM ET / 9:00 AM CT
https://www.mycme.com/courses/understanding-risk-factors-screening-and-treatment-options-in-glaEucoma-management-9315

New Prospects in Blood-based Biomarkers and Disease-Modifying Anti-Amyloid Antibody Therapies for Early-Stage Alzheimer’s Disease
Live Virtual Webinar
Date: Saturday, February 10, 2024, 11:00 AM Eastern Time, 10:00 AM Central Time and 9:00 AM Mountain Time
https://www.mycme.com/courses/new-prospects-in-blood-based-biomarkers-and-disease-modifying-anti-amyloid-antibody-therapies-for-early-stage-alzheimers-disease-9192

Changing Landscape of Diagnosis and Treatment of Multiple Myeloma
Live Virtual Webinar
Saturday, October 28, 2023 at 8:30 AM Eastern
https://www.mycme.com/courses/changing-landscape-of-diagnosis-and-treatment-of-multiple-myeloma-9053

Advances in Symptom Burden, Risk Stratification, and Treatment of Myelofibrosis
Live Virtual Webinar
Wednesday, January 18, 2023, at 7 pm Eastern
https://www.mycme.com/courses/advances-in-symptom-burden-risk-stratification-and-treatment-of-myelofibrosis-8521

New Paradigms in the Clinical Practice of Inflammatory Bowel Diseases
Live Virtual Webinar
Wednesday, November 30, 2022 at 7:00 PM EST
https://www.mycme.com/courses/new-paradigms-in-the-clinical-practice-of-inflammatory-bowel-diseases-live-event-8481

Ovarian Cancer: Mutations, Biomarkers, and Treatment with PARP Inhibitors and Immunotherapy
Live Virtual Webinar
Tuesday, October 4, 2022 at 7:00 PM EDT
https://www.mycme.com/courses/ovarian-cancer-mutations-biomarkers-and-treatment-with-parp-inhibitors-and-immunotherapy-8404

Immune Checkpoint and BRAF/MEK Inhibitor- directed Therapies for Advanced Melanoma
Live Virtual Webinar:
Wednesday, August 31, 2022 at 7 PM EDT
Rebroadcast:
Saturday, September 3, 2022 at 1 PM EDT
Tuesday, September 6, 2022 at 7 PM EDT
Thursday, September 8, 2022 at 7 PM EDT
Saturday, September 10, 2022 at 1 PM EDT
https://www.mycme.com/courses/immune-checkpoint-and-braf-mek-inhibitor-directed-therapies-for-advanced-melanoma-8345

Improving Renal Cell Carcinoma Patient Outcomes with Multi-targeted TKIs and Immune Checkpoint Inhibitors
Live Virtual Webinar
Thursday, August 18, 2022 at 7 PM EDT
Rebroadcast:
Saturday, August 20, 2022 at 1 PM EDT
Tuesday, August 23, 2022 at 7 PM EDT
Thursday, August 25, 2022 at 7 PM EDT
Saturday, August 27, 2022 at 1 PM EDT
https://www.mycme.com/courses/improving-renal-cell-carcinoma-patient-outcomes-with-multi-targeted-tkis-and-immune-checkpoint-inhibitors-8335

New and Emerging Treatment Options for CLL/SLL and MCL
Live Virtual Webinar
Wednesday, June 15, 2022 at 7 PM / 4 PM PDT

Rebroadcasts:
1) Monday, June 20, at 7pm EDT/4 PM PDT
2) Saturday, June 25, 2022, at 12 PM EDT/9 AM PDT
3) Wednesday, June 29, 2022, at 1 PM EDT /10 AM PDT
4) Thursday, June 30, 2022, at 7pm EDT/4 PM PDT
https://www.mycme.com/courses/new-and-emerging-treatment-options-for-cll-sll-and-mcl-8193

Current and Emerging Treatment Options for Multiple Myeloma
Live Virtual Webinar
Saturday, April 2, 2022 at 10 am ET

Novel Therapies for Chronic Rhinosinusitis with Nasal Polyps
Live Virtual Webinar
Monday, March 14, 2022 at 6:30 pm ET

Novel Treatment Options for Multiple Myeloma
Live Virtual Webinar
Tuesday, February 22, 2022, 6:00 PM - 8:00 PM EST
Rebroadcast - Thursday, March 3, 2022, 6:00 PM - 8:00 PM EST
https://www.mycme.com/courses/novel-treatment-options-for-multiple-myeloma-7993

Biosimilars: Implications for Clinical Practice in Inflammatory Bowel Diseases
Live Virtual Webinar
Saturday, October 30, 2021 at 10am Eastern
Rebroadcast: Saturday, November 6 at 2pm Eastern
https://www.mycme.com/courses/biosimilars-implications-for-clinical-practice-in-inflammatory-bowel-diseases-7850

Advances in the Diagnosis and Treatment of Eosinophilic Esophagitis
Live Virtual Webinar
September 29, 2021, 7pm - 8:30pm EDT
Rebroadcast: October 11, 2021, 2021, 7pm - 8:30pm EDT

Emerging Treatment Options for BRAF-mutant Colorectal Cancer
Live Virtual Webinar
August 18, 2021, 7pm - 8:30pm EDT
Rebroadcast: August 26, 2021, 7pm - 8:30pm EDT